SCHEMBL31695323

SCHEMBL31695323

Cc1ccc(-c2cc(-c3ccc(O)c(O)c3)c(C#N)c(=N)[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ PIM1 P11309 8/20 0.48
▸ MET P08581 2/20 0.44
▸ KDR P35968 2/20 0.44
▸ GLA P06280 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ APEX1 P27695 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ BIRC5 O15392 4/20 0.42
▸ ATM Q13315 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ IL4 P05112 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31695348 0.90 PIM1 (0.47) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL31695346 0.88 ATM (0.51) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL31695357 0.87 IL4 (0.45) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL31695345 0.87 ATM (0.50) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL31695313 0.87 IL4 (0.54) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL29335418 0.87 IL4 (0.54) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL29334503 0.85 PIM1 (0.67) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL31695347 0.81 ALOX5 (0.49) MAPTMEN1KMT2AALDH1A1PIM1
SCHEMBL31695290 0.80 MET (0.48) MAPTALDH1A1PIM1METKDR
SCHEMBL31695334 0.77 IL4 (0.43) MAPTMEN1KMT2AALDH1A1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 MAPT 1262/4885MEN1 3185/4885KMT2A 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback